Symbol
TRAW on Nasdaq
Investment type
Equity / Common Stock, par value $.01 per share
Latest Disclosed Ownership
404K shares
Security Ownership
9.9%

Ayrton Capital LLC ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW)

2025-02-13 - Ayrton Capital LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 404K shares of Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW). This represents 9.9% percent ownership of the company.